Oligomerix Receives Ongoing Support from NIH and Moves Forward with IND-enabling Studies

Oligomerix to Participate in the NIH Innovation Zone at 2019 BIO International Convention

Oligomerix Awarded 1.98 Million NIH SBIR-Phase IIb Grant

Oligomerix Relocates to Albert Einstein College of Medicine Campus

Oligomerix Inc. Awarded 2.49 Million Fast-Track